This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2014 Dec;35(12):1193-6.

doi: 10.1097/MNM.0000000000000205.

The future of molecular imaging in paradigm shift from reactive to proactive (P4) medicine: predictive, preventive, personalized and participatory

Majid Assadi¹, Iraj Nabipour

Affiliations

Affiliation

¹ aThe Persian Gulf Nuclear Medicine Research Center bThe Persian Gulf Tropical Medicine Research Center, Bushehr University of Medical Sciences, Bushehr cThe Future Studies Group, Iranian Academy of Medical Sciences, Tehran, Iran.

PMID: 25211627
DOI: 10.1097/MNM.0000000000000205

Editorial

The future of molecular imaging in paradigm shift from reactive to proactive (P4) medicine: predictive, preventive, personalized and participatory

Majid Assadi et al. Nucl Med Commun. 2014 Dec.

. 2014 Dec;35(12):1193-6.

doi: 10.1097/MNM.0000000000000205.

Authors

Majid Assadi¹, Iraj Nabipour

Affiliation

¹ aThe Persian Gulf Nuclear Medicine Research Center bThe Persian Gulf Tropical Medicine Research Center, Bushehr University of Medical Sciences, Bushehr cThe Future Studies Group, Iranian Academy of Medical Sciences, Tehran, Iran.

PMID: 25211627
DOI: 10.1097/MNM.0000000000000205

No abstract available

PubMed Disclaimer

Similar articles

P4 medicine: the future around the corner.
Sobradillo P, Pozo F, Agustí A. Sobradillo P, et al. Arch Bronconeumol. 2011 Jan;47(1):35-40. doi: 10.1016/j.arbres.2010.09.009. Epub 2010 Dec 28. Arch Bronconeumol. 2011. PMID: 21190770 Review. English, Spanish.
A personal view on systems medicine and the emergence of proactive P4 medicine: predictive, preventive, personalized and participatory.
Hood L, Flores M. Hood L, et al. N Biotechnol. 2012 Sep 15;29(6):613-24. doi: 10.1016/j.nbt.2012.03.004. Epub 2012 Mar 18. N Biotechnol. 2012. PMID: 22450380
Editorial: Systems biology and personalized medicine - the future is now.
Auffray C, Hood L. Auffray C, et al. Biotechnol J. 2012 Aug;7(8):938-9. doi: 10.1002/biot.201200242. Biotechnol J. 2012. PMID: 22887882
The "omics" revolution and personalized medicine.
Makhoul I. Makhoul I. J Ark Med Soc. 2012 Jun;108(13):288. J Ark Med Soc. 2012. PMID: 22799130 No abstract available.
[Introduction to preventive and predictive medicine: past experience and future reality].
Suchkov SV, Rose N, Notkins A, Golubnichaia O, von Herrath M, Legg M, Marshall T. Suchkov SV, et al. Ter Arkh. 2012;84(8):81-5. Ter Arkh. 2012. PMID: 22994097 Review. Russian.

See all similar articles

Cited by

An update on PET-based molecular imaging in neuro-oncology: challenges and implementation for a precision medicine approach in cancer care.
Shooli H, Dadgar H, Wáng YJ, Vafaee MS, Kashuk SR, Nemati R, Jafari E, Nabipour I, Gholamrezanezhad A, Assadi M, Larvie M. Shooli H, et al. Quant Imaging Med Surg. 2019 Sep;9(9):1597-1610. doi: 10.21037/qims.2019.08.16. Quant Imaging Med Surg. 2019. PMID: 31667145 Free PMC article. Review.
Precision medicine and molecular imaging: new targeted approaches toward cancer therapeutic and diagnosis.
Ghasemi M, Nabipour I, Omrani A, Alipour Z, Assadi M. Ghasemi M, et al. Am J Nucl Med Mol Imaging. 2016 Nov 30;6(6):310-327. eCollection 2016. Am J Nucl Med Mol Imaging. 2016. PMID: 28078184 Free PMC article.
Potential application of lutetium-177-labeled prostate-specific membrane antigen-617 radioligand therapy for metastatic castration-resistant prostate cancer in a limited resource environment: Initial clinical experience after 2 years.
Assadi M, Rezaei S, Jafari E, Rekabpour SJ, Ravanbod MR, Zohrabi F, Amini A, Keshmiri S, Dadgar H, Ahmadzadehfar H. Assadi M, et al. World J Nucl Med. 2020 Feb 27;19(1):15-20. doi: 10.4103/wjnm.WJNM_20_19. eCollection 2020 Jan-Mar. World J Nucl Med. 2020. PMID: 32190017 Free PMC article.
Novel Biological and Molecular Characterization in Radiopharmaceutical Preclinical Design.
Urbano N, Scimeca M, Tolomeo A, Dimiccoli V, Bonanno E, Schillaci O. Urbano N, et al. J Clin Med. 2021 Oct 21;10(21):4850. doi: 10.3390/jcm10214850. J Clin Med. 2021. PMID: 34768368 Free PMC article.

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Wolters Kluwer
Other Literature Sources
- scite Smart Citations